292 related articles for article (PubMed ID: 1406687)
1. Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor.
Rong S; Bodescot M; Blair D; Dunn J; Nakamura T; Mizuno K; Park M; Chan A; Aaronson S; Vande Woude GF
Mol Cell Biol; 1992 Nov; 12(11):5152-8. PubMed ID: 1406687
[TBL] [Abstract][Full Text] [Related]
2. Tumorigenesis induced by coexpression of human hepatocyte growth factor and the human met protooncogene leads to high levels of expression of the ligand and receptor.
Rong S; Oskarsson M; Faletto D; Tsarfaty I; Resau JH; Nakamura T; Rosen E; Hopkins RF; Vande Woude GF
Cell Growth Differ; 1993 Jul; 4(7):563-9. PubMed ID: 8398896
[TBL] [Abstract][Full Text] [Related]
3. Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation.
Rong S; Segal S; Anver M; Resau JH; Vande Woude GF
Proc Natl Acad Sci U S A; 1994 May; 91(11):4731-5. PubMed ID: 8197126
[TBL] [Abstract][Full Text] [Related]
4. Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts.
Rygaard K; Nakamura T; Spang-Thomsen M
Br J Cancer; 1993 Jan; 67(1):37-46. PubMed ID: 7678980
[TBL] [Abstract][Full Text] [Related]
5. Autocrine mechanism for met proto-oncogene tumorigenicity.
Rong S; Vande Woude GF
Cold Spring Harb Symp Quant Biol; 1994; 59():629-36. PubMed ID: 7587123
[No Abstract] [Full Text] [Related]
6. The Met proto-oncogene mesenchymal to epithelial cell conversion.
Tsarfaty I; Rong S; Resau JH; Rulong S; da Silva PP; Vande Woude GF
Science; 1994 Jan; 263(5143):98-101. PubMed ID: 7505952
[TBL] [Abstract][Full Text] [Related]
7. The Met-HGF/SF autocrine signaling mechanism is involved in sarcomagenesis.
Cortner J; Vande Woude GF; Rong S
EXS; 1995; 74():89-121. PubMed ID: 8527903
[TBL] [Abstract][Full Text] [Related]
8. Deletion of the ectodomain unleashes the transforming, invasive, and tumorigenic potential of the MET oncogene.
Merlin S; Pietronave S; Locarno D; Valente G; Follenzi A; Prat M
Cancer Sci; 2009 Apr; 100(4):633-8. PubMed ID: 19175607
[TBL] [Abstract][Full Text] [Related]
9. Properties and functions of scatter factor/hepatocyte growth factor and its receptor c-Met.
Weidner KM; Hartmann G; Sachs M; Birchmeier W
Am J Respir Cell Mol Biol; 1993 Mar; 8(3):229-37. PubMed ID: 8383506
[TBL] [Abstract][Full Text] [Related]
10. Efficient cell transformation by the Tpr-Met oncoprotein is dependent upon tyrosine 489 in the carboxy-terminus.
Fixman ED; Naujokas MA; Rodrigues GA; Moran MF; Park M
Oncogene; 1995 Jan; 10(2):237-49. PubMed ID: 7838524
[TBL] [Abstract][Full Text] [Related]
11. Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists.
Michieli P; Basilico C; Pennacchietti S; Maffè A; Tamagnone L; Giordano S; Bardelli A; Comoglio PM
Oncogene; 1999 Sep; 18(37):5221-31. PubMed ID: 10498872
[TBL] [Abstract][Full Text] [Related]
12. The role of non-ras transforming genes in chemical carcinogenesis.
Cooper CS
Environ Health Perspect; 1991 Jun; 93():33-40. PubMed ID: 1685444
[TBL] [Abstract][Full Text] [Related]
13. From Tpr-Met to Met, tumorigenesis and tubes.
Peschard P; Park M
Oncogene; 2007 Feb; 26(9):1276-85. PubMed ID: 17322912
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor-scatter factor (HGF-SF) and the c-met receptor. Introduction.
Goldberg ID; Rosen EM
EXS; 1993; 65():xiii-xv. PubMed ID: 8380733
[No Abstract] [Full Text] [Related]
15. The cell dissociation and motility triggered by scatter factor/hepatocyte growth factor are mediated through the cytoplasmic domain of the c-Met receptor.
Komada M; Kitamura N
Oncogene; 1993 Sep; 8(9):2381-90. PubMed ID: 7689722
[TBL] [Abstract][Full Text] [Related]
16. Met expression and sarcoma tumorigenicity.
Rong S; Jeffers M; Resau JH; Tsarfaty I; Oskarsson M; Vande Woude GF
Cancer Res; 1993 Nov; 53(22):5355-60. PubMed ID: 7693339
[TBL] [Abstract][Full Text] [Related]
17. Isoforms of human HGF and their biological activities.
Chan A; Rubin J; Bottaro D; Hirschfield D; Chedid M; Aaronson SA
EXS; 1993; 65():67-79. PubMed ID: 8380745
[TBL] [Abstract][Full Text] [Related]
18. Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells.
Jeffers M; Rong S; Anver M; Vande Woude GF
Oncogene; 1996 Aug; 13(4):853-6. PubMed ID: 8761307
[TBL] [Abstract][Full Text] [Related]
19. Molecular characteristics of HGF-SF and its role in cell motility and invasion.
Weidner KM; Hartmann G; Naldini L; Comoglio PM; Sachs M; Fonatsch C; Rieder H; Birchmeier W
EXS; 1993; 65():311-28. PubMed ID: 8380739
[TBL] [Abstract][Full Text] [Related]
20. Decreased fibronectin expression in Met/HGF-mediated tumorigenesis.
Taylor GA; Jeffers M; Webb CP; Koo HM; Anver M; Sekiguchi K; Vande Woude GF
Oncogene; 1998 Sep; 17(9):1179-83. PubMed ID: 9764829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
